The treatment of urticaria pigmentosa with the frequency-doubled Q-switch Nd:YAG laser

Journal of Cosmetic and Laser Therapy

Volumn 2, Issue 1, 2000, Pages 45-47

  Bedlow, A J ^a   Gharrie, S ^b   Harland, C C ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

Author keywords

Nd:YAG laser; treatment; urticaria pigmentosa

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ESTHETIC SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SPECTRAL SENSITIVITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URTICARIA PIGMENTOSA; YAG LASER;

EID: 0033890342     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14628830050516614     Document Type: Article

References (5)

1. Granerus G, Roupe G, Swanbeck G. Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa. J Invest Dermatol 1983; 80: 410-16.
2. Alster TS, Lewis AB. Dermatologic laser surgery. Dermatol Surg 1996; 22: 797-805.
3. Spicer MS, Goldberg DJ. Lasers in dermatology. J Am Acad Dermatol 1996; 34: 1-25. (Pubitemid 126510078)
4. Ellis DL. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flash-pumped dye laser. Dermatologic Surg 1996; 22: 33-7. (Pubitemid 26038733)
5. El Sayed SO, Dyson M. Effect of laser pulse repetition rate and pulse duration on mast cell number and degranulation. Lasers Surg Med 1996; 19: 433-7. (Pubitemid 27024247)